Equally, myeloid-derived suppressor cells (MDSCs), which potently inhibit adaptive immune responses, can be targeted by HDL interactions with SR-B1 to deliver a possible anti-tumour immune response. This evidence concerns the gene SCARB1 and neoplasm.